NCT02261285View on ClinicalTrials.gov

ONO-4538 Phase I Study in Patients With Solid Tumor

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Advanced Solid TumorsRecurrent Solid Tumors
Interventions
DRUG

ONO-4538

Trial Locations (5)

Unknown

Seongnam-si Clinical Site 105, Seongnam-si

Seoul Clinical Site 101, Seoul

Seoul Clinical Site 102, Seoul

Seoul Clinical Site 103, Seoul

Seoul Clinical Site 104, Seoul

Sponsors
All Listed Sponsors
lead

Ono Pharmaceutical Co. Ltd

INDUSTRY